亚洲中文久久精品无码WW16,亚洲国产精品久久久久爰色欲,人人妻人人澡人人爽欧美一区九九,亚洲码欧美码一区二区三区

產品展廳收藏該商鋪

您好 登錄 注冊

當前位置:
上海恒遠生物科技有限公司>公司動態>研究表明LRG1對于在眼病中控制病理性血管治療目標

公司動態

研究表明LRG1對于在眼病中控制病理性血管治療目標

閱讀:1404          發布時間:2013-7-23

LRG1 promotes angiogenesis by modulating endothelial TGF-β signalling

Xiaomeng Wang, Sabu Abraham, Jenny A. G. McKenzie, Natasha Jeffs, Matthew Swire, Vineeta B. Tripathi, Ulrich F. O. Luhmann, Clemens A. K. Lange, Zhenhua Zhai, Helen M. Arthur, James W. B. Bainbridge, Stephen E. Moss & John Greenwood

Aberrant neovascularization contributes to diseases such as cancer, blindness and atherosclerosis, and is the consequence of inappropriate angiogenic signalling. Although many regulators of pathogenic angiogenesis have been identified, our understanding of this process is incomplete. Here we explore the transcriptome of retinal microvessels isolated from mouse models of retinal disease that exhibit vascular pathology, and uncover an upregulated gene, leucine-rich alpha-2-glycoprotein 1 (Lrg1), of previously unknown function. We show that in the presence of transforming growth factor-β1 (TGF-β1), LRG1 is mitogenic to endothelial cells and promotes angiogenesis. Mice lacking Lrg1 develop a mild retinal vascular phenotype but exhibit a significant reduction in pathological ocular angiogenesis. LRG1 binds directly to the TGF-β accessory receptor endoglin, which, in the presence of TGF-β1, results in promotion of the pro-angiogenic Smad1/5/8 signalling pathway. LRG1 antibody blockade inhibits this switch and attenuates angiogenesis. These studies reveal a new regulator of angiogenesis that mediates its effect by modulating TGF-β signalling.

    選擇恒遠生物,您將得到高質量的產品、實惠的價格、的服務、快捷的到貨、穩定的貨源、;
 !我們會定期推出市場活動,及時給您提供足夠的市場*和產品資料!我們提供一切售前支持和售后服務!我們的http://www.rdelisa.com 可以查到大部分產品詳細信息、價格(具體產品說明書可以找我們索取),它必將成為您和您客戶的有力工具!

收藏該商鋪

登錄 后再收藏

提示

您的留言已提交成功!我們將在第一時間回復您~

對比框

產品對比 產品對比 聯系電話 二維碼 在線交流

掃一掃訪問手機商鋪
13636351217
在線留言